Pharmacy Freak Editorial Team

Approval procedures and documentation for new drug applications introduce B. Pharm students to the regulatory framework, dossier structure, and evidence required to gain market authorization. This topic covers NDA/ANDA/505(b)(2) pathways, IND filings, CTD/eCTD format, CMC (Chemistry, Manufacturing & Controls), nonclinical and clinical data, bioavailability/bioequivalence studies, stability, GMP, pharmacovigilance and risk management plans. Understanding regulatory authorities … Read more

Introduction: Regulatory requirements for new drug approval in India cover legal frameworks, clinical trial approvals, documentation, and post‑marketing surveillance. B. Pharm students must understand key terms and authorities such as CDSCO, DCGI, NDCTR‑2019, Schedule Y, CTRI, GCP, CTD dossier, GMP certification, stability studies, bioavailability/bioequivalence, ethics committee approval, informed consent, and pharmacovigilance. Practical knowledge includes clinical … Read more

Certificate of Pharmaceutical Product (COPP) is a regulatory document issued by a competent National Regulatory Authority (NRA) that certifies a medicinal product’s marketing authorization, approved manufacturer, dosage form, strength, shelf-life and often compliance with Good Manufacturing Practice (GMP). For B.Pharm students, understanding COPP procedure and significance is essential for export, drug registration, quality assurance and … Read more

The Central Drugs Standard Control Organization (CDSCO) is India’s central drug regulatory authority responsible for drug approval, device regulation, clinical trial oversight, licensing, and pharmacovigilance. Understanding CDSCO organization and responsibilities is essential for B. Pharm students because it links regulatory policy with pharmacy practice, drug safety, quality control, and compliance. This topic covers CDSCO structure, … Read more

The Indian regulatory framework for pharmaceuticals is anchored in the Drugs and Cosmetics Act, 1940 and Rules, 1945, with the Central Drugs Standard Control Organization (CDSCO) and State Licensing Authorities (SLAs) sharing responsibilities. CDSCO (headed by the DCGI) oversees new drug approvals, clinical trial permissions, import licensing, pharmacovigilance and national standards, while SLAs handle state-level … Read more

NABL accreditation and Good Laboratory Practices (GLP) are essential for B.Pharm students to understand laboratory quality, compliance, and data integrity. NABL accreditation (ISO/IEC 17025) assesses technical competence, method validation, calibration, traceability, uncertainty, and quality management systems in testing and calibration labs. GLP (OECD principles) ensures reliable non‑clinical safety study conduct through clear roles, SOPs, study … Read more

Overview of ISO 14000 environmental management systems MCQs With Answer This concise guide introduces B. Pharm students to ISO 14000 and Environmental Management Systems (EMS), focusing on compliance, pollution prevention, waste management, and sustainable pharmaceutical practices. It explains core concepts such as the PDCA cycle, environmental policy, legal requirements, life‑cycle thinking, documentation, auditing, and continual … Read more

Introduction to ISO 9000 series of quality system standards MCQs With Answer The ISO 9000 series provides international guidance on quality management systems (QMS), defining terms, principles and the framework used by organizations worldwide. For B.Pharm students, understanding ISO 9000, ISO 9001 requirements, quality assurance, documentation, process approach, risk-based thinking, continual improvement and audit principles … Read more

Introduction: Change control procedures and documentation are core elements of pharmaceutical quality systems that ensure any modification to processes, equipment, materials, or documents is assessed, authorized, implemented, and tracked under Good Manufacturing Practice (GMP). For B. Pharm students, understanding change control, SOP updates, risk assessment, validation impact, CAPA linkage, and regulatory expectations (FDA/EMA/WHO) is essential … Read more